Moderna shares hit fresh 52-week high after Nasdaq-100 return
Moderna (MRNA) closed up about 14% at $225 after setting a new 52-week high and re-entering the Nasdaq-100.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Moderna (MRNA) closed up about 14% at $225 after setting a new 52-week high and re-entering the Nasdaq-100.
Bitcoin rallies above $77,000, U.S. equities steady, and S&P Global’s flash composite PMI jumps to 56.0 in August from 54.5, while gold hits a three-month high.